HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET.

Abstract
Sigma receptors are expressed in a wide variety of tumor cell lines, and are expressed in proliferating cells. A radioligand for the visualization of sigma receptors could be useful for selective detection of primary tumors and their metastases, and for non-invasive assessment of tumor proliferative status. To this end we evaluated two sigma receptor ligands, [11C]SA5845 and [11C]SA4503. In an in vitro study, AH109A hepatoma showed moderate densities of sigma1 and sigma2 receptors, and VX-2 carcinoma showed a high density of sigma2 receptors: Bmax (fmol/mg protein) for sigma1 vs. sigma2, 1,700 vs. 1,200 for AH109A hepatoma and 800 vs. 10,000 for VX-2 carcinoma. In a cell growth assay in vitro, neither SA5845 nor SA4503 (<10 microM) showed any inhibitory effect on proliferation of the AH109A hepatoma cells. In rats, the uptake of [11C]SA5845 and [11C]SA4503 in AH109A tissues was accumulated over the first 60 minutes; however, the uptake of both tracers increased by co-injection with haloperidol as a sigma receptor ligand. On the other hand, in the PET studies of rabbits, the uptake of [11C]SA5845 in the VX-2 carcinoma was relatively higher than that of [11C]SA4503, because of a much higher density of sigma2 receptors compared to sigma1 receptors in the VX-2 tissue, and the uptake of both tracers in the VX-2 tissue was decreased by carrier-loading and pre-treatment with haloperidol ([11C]SA5845, 53% and 26%, respectively; [11C]SA4503, 41% and 22%, respectively at 30 minutes after injection). Therefore, [11C]SA5845 and [11C]SA4503 may be potential ligands for PET imaging of sigma receptor-rich tumors.
AuthorsKazunori Kawamura, Kazuo Kubota, Tadayuki Kobayashi, Philip H Elsinga, Mayumi Ono, Minoru Maeda, Kiichi Ishiwata
JournalAnnals of nuclear medicine (Ann Nucl Med) Vol. 19 Issue 8 Pg. 701-9 (Dec 2005) ISSN: 0914-7187 [Print] Japan
PMID16444997 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Carbon Radioisotopes
  • Piperazines
  • Radiopharmaceuticals
  • Receptors, sigma
  • SA5845
  • SA 4503
Topics
  • Animals
  • Biomarkers, Tumor (metabolism)
  • Carbon Radioisotopes (pharmacokinetics)
  • Carcinoma (diagnostic imaging, metabolism)
  • Carcinoma, Hepatocellular (diagnostic imaging, metabolism)
  • Drug Evaluation, Preclinical
  • Male
  • Metabolic Clearance Rate
  • Organ Specificity
  • Piperazines (pharmacokinetics)
  • Positron-Emission Tomography (methods)
  • Rabbits
  • Radiopharmaceuticals (pharmacokinetics)
  • Rats
  • Receptors, sigma (metabolism)
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: